about us | Call Us Now +919975001999 50+ Awards Won 5000+ Happy Clients 20+ Running Projects 100+ Team Member Industries We Serve Industries & MNCs Education Institutions Govt
Emerging players advance differentiated mechanisms, including Pfizer's partnership for a phase 1 small-molecule agonist and Amgen's novel candidates
For Zepbound, 109 million people have lost their coverage, up 12% from last year
SUPPORT NATURAL GROWTH HORMONE PRODUCTION
In toxin-induced PD mouse models, DA-JC1, a novel dual GLP-1/GIP receptor agonist, improved motor impairment, increased the number of dopaminergic neurons in the substantia nigra, enhanced BDNF levels, and modulated apoptosis signaling pathways by altering the expression of Bax and Bcl-2 [89, 90]